Covered recipient · General Payments record
MARLON C DECASTRO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,215.71
- Reported across 293 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $276.90 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $149.57 | 11 |
| Amgen Inc. | $51.09 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.87 | 1 |
| GlaxoSmithKline, LLC. | $18.72 | 1 |
| Acerta Pharma LLC | $17.73 | 1 |
| iRhythm Technologies, Inc. | $16.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.07 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111560525 | CMS |
| Amgen Inc. | $28.02 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111560527 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.73 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105707430 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.87 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118152013 | CMS |
| GlaxoSmithKline, LLC. | $18.72 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116519916 | CMS |
| iRhythm Technologies, Inc. | $16.92 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154046231 | CMS |
| PFIZER INC. | $15.20 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572645 | CMS |
| PFIZER INC. | $10.18 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132047276 | CMS |
| PFIZER INC. | $10.87 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132046754 | CMS |
| PFIZER INC. | $12.00 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132045532 | CMS |
| PFIZER INC. | $15.00 | 04/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131689760 | CMS |
| PFIZER INC. | $14.96 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131580075 | CMS |
| PFIZER INC. | $16.45 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131600837 | CMS |
| PFIZER INC. | $15.36 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131591929 | CMS |
| PFIZER INC. | $12.42 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132059542 | CMS |
| PFIZER INC. | $15.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132113379 | CMS |
| PFIZER INC. | $11.93 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131183892 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.